[Attitude of the adult patient with atopic dermatitis to the disease and its treatment: the ACTIDA Study]

Actas Dermosifiliogr. 2010 Mar;101(2):143-50.
[Article in Spanish]

Abstract

Objective: To determine the attitude of adult patients with atopic dermatitis (AD) to their disease and its treatment.

Material and methods: A multicenter, cross-sectional study was performed in patients with at least 2 outbreaks of AD in the previous year.

Results: Two hundred twenty-seven dermatologists recruited 1441 analyzable patients, the majority women, with a mean of 3.6 outbreaks per year. Most of the patients (97.2%) indicated that they always or sometimes requested medical evaluation of a new outbreak. In the most recent outbreak, 72.2% had used combined therapy, regardless of the severity of the episode; 2-drug combinations were the most common. The majority of dermatologists prescribed combined therapy, most commonly a 2-drug combination for mild or minimal disease, and 3 or more drugs for moderate to very severe outbreaks.

Conclusions: Treatments used by patients for an outbreak of AD are similar to those prescribed by dermatologists in recent outbreaks.

Publication types

  • English Abstract
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Attitude to Health*
  • Cross-Sectional Studies
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / psychology*
  • Dermatologic Agents / therapeutic use*
  • Drug Therapy / psychology
  • Drug Therapy, Combination
  • Female
  • Histamine Antagonists / administration & dosage
  • Histamine Antagonists / therapeutic use
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Office Visits / statistics & numerical data
  • Patient Acceptance of Health Care / statistics & numerical data
  • Patients / psychology*
  • Quality of Life
  • Spain
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Histamine Antagonists
  • Immunosuppressive Agents